Comparative bioavailability of Neoral and Sandimmune in cardiac transplant recipients over 1 year.
Cooney
G F
GF
Temple University Hospital, Philadelphia, PA, USA. daycooney@aol.com
Jeevanandam
V
V
Choudhury
S
S
Feutren
G
G
Mueller
E A
EA
Eisen
H J
HJ
D000284:Administration, Oral; D001682:Biological Availability; D016572:Cyclosporine / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D016027:Heart Transplantation / Q000276:immunology* / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine